Inflammatory
TNF-Blocking Therapies
Interleukin-1 Inhibition
Overview of Rheumatoid Arthritis
Higher adjusted AKI rate with inflammatory bowel disease vs. collagen vascular diseases
The frequency and risk of AKI in patients hospitalized with inflammatory bowel disease is higher compared with admissions with collagen vascular diseases and from the general population, a recently published study shows.
Common Symptoms
Blood tests may predict which patients with lymphoma will have poor outcomes after CAR-T
Two blood biomarkers — pre-lymphodepletion C-reactive protein and ferritin — may help predict which patients with lymphoma are at risk for poor outcomes after chimeric antigen receptor T-cell therapy.
JAK inhibitors have ‘untapped potential’ in treatment of inflammatory skin diseases
MIAMI BEACH, Fla. — Janus kinase inhibitors have a unique mechanism of action, giving them the potential to push the boundaries of efficacy in the treatment of inflammatory skin diseases, according to a speaker at South Beach Symposium.
Aviceda reports positive topline data for AVD-104 in patients with geographic atrophy
Aviceda Therapeutics announced positive safety and efficacy outcomes from part 1 of its phase 2/3 SIGLEC trial for AVD-104, which is being evaluated in patients with geographic atrophy secondary to age-related macular degeneration.
Sexually diverse patients with inflammatory skin diseases experience barriers to care
Patients in sexual and gender minorities who have chronic inflammatory skin diseases often experience financial and non-financial barriers to care, according to a study.
Guide to prescribing methotrexate to pediatric patients with inflammatory skin diseases
In a panel-led project, 23 experts created a comprehensive guide for the long-term management of inflammatory skin diseases in pediatric patients treated with methotrexate.